Società Granules India Ltd. NSE India S.E.
Azioni
INE101D01012
Prodotti farmaceutici
Prezzo di chiusura
Altri mercati azionari
|
||
- INR | - |
Attività
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
99,7
%
| 37 272 | 99,0 % | 44 963 | 99,7 % | +20,64% |
Other
0,3
%
| 377 | 1,0 % | 156 | 0,3 % | -58,73% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
93,6
%
| 27 821 | 85,9 % | 42 224 | 93,6 % | +51,77% |
India
6,4
%
| 4 563 | 14,1 % | 2 895 | 6,4 % | -36,55% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 60 | 05/01/22 | |
Chief Executive Officer | 69 | 18/03/91 | |
Mukesh Surana
DFI | Director of Finance/CFO | 44 | 30/12/22 |
Chief Tech/Sci/R&D Officer | - | - | |
P.V. Srinivas
CTO | Chief Tech/Sci/R&D Officer | - | - |
GSR Prasad
COO | Chief Operating Officer | - | 01/01/17 |
Compliance Officer | - | - | |
Sanjay Kumar
PRN | Corporate Officer/Principal | - | 01/12/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 70 | 19/02/13 | |
Director/Board Member | 62 | 13/12/21 | |
Arun Sawhney
BRD | Director/Board Member | 68 | 29/10/18 |
Chief Executive Officer | 69 | 18/03/91 | |
Director/Board Member | 64 | 23/01 | |
Director/Board Member | 40 | 01/01/05 | |
Director/Board Member | 64 | 31/05/12 | |
Director/Board Member | - | 23/01 | |
Director/Board Member | - | 22/12/21 | |
Chief Executive Officer | 60 | 05/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 242 368 716 | 129 120 408 ( 53,27 %) | 0 | 53,27 % |
Coordinate società
Granules India Ltd.
My Home Hub 2nd Floor, 3rd Block
500081, Hyderabad
+91 40 6904 3500
http://www.granulesindia.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Granules Pharmaceuticals, Inc.
Granules Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Granules Pharmaceuticals, Inc. develops and manufactures pharmaceutical formulations. The firm manufactures tablets, pharmaceutical formulation intermediates and active pharmaceutical ingredients. The company is headquartered in Chantilly, VA. |
Pharmaceuticals: Major
|
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+48,39% | 779 Mrd | |
-6,13% | 354 Mrd | |
+20,61% | 333 Mrd | |
+10,00% | 301 Mrd | |
+19,43% | 249 Mrd | |
-1,68% | 216 Mrd | |
+11,81% | 214 Mrd | |
+5,80% | 163 Mrd | |
-2,50% | 159 Mrd |
- Borsa valori
- Azioni
- Azione GRANULES
- Azione
- Società Granules India Ltd.